These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11115726)

  • 41. Optimal induction of T-cell responses against hepatitis C virus E2 by antigen engineering in DNA immunization.
    Youn JW; Park SH; Cho JH; Sung YC
    J Virol; 2003 Nov; 77(21):11596-602. PubMed ID: 14557645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A candidate DNA vaccine elicits HCV specific humoral and cellular immune responses.
    Zhu LX; Liu J; Ye Y; Xie YH; Kong YY; Li GD; Wang Y
    World J Gastroenterol; 2004 Sep; 10(17):2488-92. PubMed ID: 15300890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA-based immunization breaks tolerance in a hepatitis C virus transgenic mouse model.
    Encke J; Geissler M; Stremmel W; Wands JR
    Hum Vaccin; 2006; 2(2):78-83. PubMed ID: 17012868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Immune responses to recombinant expression plasmid encoding hepatitis C virus core antigen].
    Feng Z; Zhou Y; Jia Z; Lian J; Li J; Li W
    Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):462-5. PubMed ID: 11798682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repeated administration of hepatitis C virus core-encoding plasmid to mice does not necessarily increase the immune response generated against this antigen.
    Dueñas-Carrera S; Alvarez-Lajonchere L; Alvarez JC; Ramos T; Pichardo D; Morales J
    Biotechnol Appl Biochem; 2001 Feb; 33(1):47-51. PubMed ID: 11171035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of immunization in mice with recombinant DNA encoding the hepatitis C virus structural protein.
    Dou J; Liu K; Chen Z; Wo J; He N; Liu Y; Zhang M; Wang X; Xu C
    Chin Med J (Engl); 1999 Nov; 112(11):1036-9. PubMed ID: 11721468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of refractory T cell responses against hepatitis C virus core protein by ablation of interfering hydrophobic domains.
    Andersson HA; Singh RA; Barry MA
    Mol Ther; 2006 Feb; 13(2):338-46. PubMed ID: 16242998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
    Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
    Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins.
    Pancholi P; Liu Q; Tricoche N; Zhang P; Perkus ME; Prince AM
    J Infect Dis; 2000 Jul; 182(1):18-27. PubMed ID: 10882577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunization with a synthetic multiepitope antigen induces humoral and cellular immune responses to hepatitis C virus in mice.
    Chen L; Gao T; Yang N; Huang J; Chen Y; Gao T; Li Q; Ren D
    Viral Immunol; 2007; 20(1):170-9. PubMed ID: 17425431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of antibody- and cell-mediated immune responses after intramuscular hepatitis C immunizations of BALB/c mice.
    Ghorbani M; Nass T; Azizi A; Soare C; Aucoin S; Giulivi A; Anderson DE; Diaz-Mitoma F
    Viral Immunol; 2005; 18(4):637-48. PubMed ID: 16359230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid.
    Major ME; Vitvitski L; Mink MA; Schleef M; Whalen RG; Trépo C; Inchauspé G
    J Virol; 1995 Sep; 69(9):5798-805. PubMed ID: 7637024
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a heterologous, multigenotype vaccine against hepatitis C virus infection.
    Encke J; Radunz W; Eisenbach C; Geib J; Gehrke S; Pfaff E; Stremmel W
    Eur J Clin Invest; 2007 May; 37(5):396-406. PubMed ID: 17461986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune responses to plasmid DNA encoding the hepatitis C virus core protein.
    Lagging LM; Meyer K; Hoft D; Houghton M; Belshe RB; Ray R
    J Virol; 1995 Sep; 69(9):5859-63. PubMed ID: 7637033
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Expression and immune response to hepatitis C virus core gene combined hepatitis B virus core gene with two multiple cloning sites vector].
    Deng T; Fan G; Chen T; Chen N; Hu D; Wang M; Jia K
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(2):77-80. PubMed ID: 11953132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
    Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
    Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced cell immune responses to hepatitis C virus core by novel heterologous DNA prime/lambda nanoparticles boost in mice.
    Saeedi A; Ghaemi A; Tabarraei A; Moradi A; Gorji A; Semnani S; Soleimanjahi H; Adli AH; Hosseini SY; Vakili MA
    Virus Genes; 2014 Aug; 49(1):11-21. PubMed ID: 24752903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice.
    Ma X; Forns X; Gutierrez R; Mushahwar IK; Wu T; Payette PJ; Bukh J; Purcell RH; Davis HL
    Vaccine; 2002 Sep; 20(27-28):3263-71. PubMed ID: 12213395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancement of the immune response generated against hepatitis C virus envelope proteins after DNA vaccination with polyprotein-encoding plasmids.
    Dueñas-Carrera S; Alvarez-Lajonchere L; César Alvarez-Obregón J; Pérez A; Acosta-Rivero N; Vázquez DM; Martínez G; Viña A; Pichardo D; Morales J
    Biotechnol Appl Biochem; 2002 Jun; 35(3):205-12. PubMed ID: 12074699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.